Literature DB >> 30291359

Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.

David F McDermott1, Mahrukh A Huseni2, Michael B Atkins3, Robert J Motzer4, Brian I Rini5, Bernard Escudier6, Lawrence Fong7, Richard W Joseph8, Sumanta K Pal9, James A Reeves10, Mario Sznol11, John Hainsworth12, W Kimryn Rathmell13, Walter M Stadler14, Thomas Hutson15, Martin E Gore16, Alain Ravaud17, Sergio Bracarda18, Cristina Suárez19, Riccardo Danielli20, Viktor Gruenwald21, Toni K Choueiri22, Dorothee Nickles2, Suchit Jhunjhunwala2, Elisabeth Piault-Louis2, Alpa Thobhani23, Jiaheng Qiu2, Daniel S Chen2, Priti S Hegde2, Christina Schiff2, Gregg D Fine2, Thomas Powles24.   

Abstract

In the version of this article originally published, there was an error in Fig. 2n. The top line of the HR comparison chart originally was Atezo + bev vs sun. It should have been Atezo + bev vs atezo. The error has been corrected in the HTML and PDF versions of this article.

Entities:  

Year:  2018        PMID： 30291359     DOI： 10.1038/s41591-018-0235-z

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


  10 in total

1.  Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors.

Authors:  Sarah Abou Alaiwi; Amin H Nassar; Wanling Xie; Ziad Bakouny; Jacob E Berchuck; David A Braun; Sylvan C Baca; Pier Vitale Nuzzo; Ronan Flippot; Tarek H Mouhieddine; Liam F Spurr; Yvonne Y Li; Taiwen Li; Abdallah Flaifel; John A Steinharter; Claire A Margolis; Natalie I Vokes; Heng Du; Sachet A Shukla; Andrew D Cherniack; Guru Sonpavde; Robert I Haddad; Mark M Awad; Marios Giannakis; F Stephen Hodi; X Shirley Liu; Sabina Signoretti; Cigall Kadoch; Matthew L Freedman; David J Kwiatkowski; Eliezer M Van Allen; Toni K Choueiri
Journal:  Cancer Immunol Res       Date:  2020-04-22       Impact factor: 11.151

Review 2.  Tissue-resident memory T cells in the kidney.

Authors:  Nariaki Asada; Pauline Ginsberg; Nicola Gagliani; Hans-Willi Mittrücker; Ulf Panzer
Journal:  Semin Immunopathol       Date:  2022-04-11       Impact factor: 9.623

Review 3.  Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma.

Authors:  Alexandre Ingels; Riccardo Campi; Umberto Capitanio; Daniele Amparore; Riccardo Bertolo; Umberto Carbonara; Selcuk Erdem; Önder Kara; Tobias Klatte; Maximilian C Kriegmair; Michele Marchioni; Maria C Mir; Idir Ouzaïd; Nicola Pavan; Angela Pecoraro; Eduard Roussel; Alexandre de la Taille
Journal:  Nat Rev Urol       Date:  2022-05-11       Impact factor: 16.430

4.  Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes.

Authors:  Tianshi Lu; Shidan Wang; Lin Xu; Qinbo Zhou; Nirmish Singla; Jianjun Gao; Subrata Manna; Laurentiu Pop; Zhiqun Xie; Mingyi Chen; Jason J Luke; James Brugarolas; Raquibul Hannan; Tao Wang
Journal:  Sci Immunol       Date:  2020-02-21

5.  Editorial Commentary: Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study.

Authors:  Mary E Westerman; Christopher G Wood
Journal:  Ann Transl Med       Date:  2020-08

6.  Relationship Between Progression-Free Survival, Objective Response Rate, and Overall Survival in Clinical Trials of PD-1/PD-L1 Immune Checkpoint Blockade: A Meta-Analysis.

Authors:  Jiabu Ye; Xiang Ji; Phillip A Dennis; Hesham Abdullah; Pralay Mukhopadhyay
Journal:  Clin Pharmacol Ther       Date:  2020-07-18       Impact factor: 6.875

7.  Synthesis and Biological Evaluation of Oleanolic Acid Derivatives as Selective Vascular Endothelial Growth Factor Promoter i-Motif Ligands.

Authors:  Huang Zeng; Shuangshuang Kang; Yu Zhang; Ke Liu; Qian Yu; Ding Li; Lin-Kun An
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

8.  Global Characterization of Immune Infiltration in Clear Cell Renal Cell Carcinoma.

Authors:  Yan Zheng; Yibo Wen; Huixia Cao; Yue Gu; Lei Yan; Yanliang Wang; Limeng Wang; Lina Zhang; Fengmin Shao
Journal:  Onco Targets Ther       Date:  2021-03-22       Impact factor: 4.147

9.  Antitumor effect of isoquercetin on tissue vasohibin expression and colon cancer vasculature.

Authors:  Daniel de Castilho da Silva; Guilherme Di Camillo Orfali; Maycon Giovani Santana; Jessica Kaoru Yamamoto Palma; Isabella Ramos de Oliveira Assunção; Isadora Moraes Marchesi; Ana Yoshie Kitagawa Grizotto; Natália Peres Martinez; Simone Felliti; José Aires Pereira; Denise Gonçalves Priolli
Journal:  Oncotarget       Date:  2022-02-08

10.  Efficacy of sintilimab and fruquintinib combination treatment in the management of microsatellite-stable metastatic colorectal cancer: a case report.

Authors:  Sen Lin; Weiyi Chen; Zhuangzhong Chen; Jiaqi Liang; Ling Zhong; Mei Jiang
Journal:  Ann Transl Med       Date:  2022-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.